Latest News

The company’s presentations at EASL 2026 build on results from the Phase 3 ESSENCE programme, where semaglutide 2.4 mg previously demonstrated significant reductions in liver inflammation and fibrosis among patients with MASH.

Under the licensing arrangement, the Medicines Patent Pool (MPP) has invited qualified generic drug manufacturers to submit applications to produce generic versions of Xofluza.

Authorities also dispatched a team of 35 experts from Kinshasa to reinforce surveillance, infection prevention and control, contact tracing, and community engagement efforts in the affected areas.

Under the collaboration, the companies will evaluate Helicons both as standalone therapies and as payloads linked to Regeneron antibodies.

This agreement also grants Boston Scientific an exclusive option to acquire the TAVR programme, subject to additional payments and to clinical and regulatory milestones.

The facility is built to accommodate approximately 1,000 to 1,500 healthcare professionals each year, including consultants, specialists, and early-career doctors.

The JV combines Arna Pharma’s formulation development expertise and portfolio expansion strategy with Slate Run Pharmaceuticals’ established US commercial operations, regulatory capabilities, and supply chain infrastructure.

The antiviral drug was originally designed to treat influenza but has also attracted attention for its potential activity against other RNA viruses.

The initiative, implemented with the Ministry of Health in Ghana, arrives at a time when countries are increasingly adopting digital technologies to address complex health challenges such as climate-sensitive diseases and unequal access to care.

The launch brings together national and international health stakeholders who are supporting Nigeria’s broader HIV response strategy.